Found: 46
Select item for more details and to access through your institution.
Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2022, v. 480, n. 3, p. 655, doi. 10.1007/s00428-021-03228-w
- By:
- Publication type:
- Article
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.
- Published in:
- Cancer Reports, 2022, v. 5, n. 7, p. 1, doi. 10.1002/cnr2.1524
- By:
- Publication type:
- Article
Use of Alternative Medicine Among Norwegian Cancer Patients is Associated with Mental Distress - A Follow-up Study.
- Published in:
- Acta Oncologica, 2002, v. 41, n. 7/8, p. 646, doi. 10.1080/028418602321028265
- By:
- Publication type:
- Article
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 4, p. 488, doi. 10.1038/s41587-021-01089-x
- By:
- Publication type:
- Article
Infiltration of CD163‐, PD‐L1‐ and FoxP3‐positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. 520, doi. 10.1111/bjh.17366
- By:
- Publication type:
- Article
p53 is associated with high‐risk and pinpoints TP53 missense mutations in mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 5, p. 796, doi. 10.1111/bjh.17023
- By:
- Publication type:
- Article
The MCL35 gene expression proliferation assay predicts high‐risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 2, p. 225, doi. 10.1111/bjh.15518
- By:
- Publication type:
- Article
15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial ( MCL2): prolonged remissions without survival plateau.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 3, p. 410, doi. 10.1111/bjh.14241
- By:
- Publication type:
- Article
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 3, p. 432, doi. 10.1111/bjh.13965
- By:
- Publication type:
- Article
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 1, p. 98, doi. 10.1111/bjh.12854
- By:
- Publication type:
- Article
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Radiotherapy Compared to Other Strategies in the Treatment of Stage I/II Follicular Lymphoma: A Study of 404 Patients with a Median Follow-Up of 15 Years.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0131158
- By:
- Publication type:
- Article
The Patient Experiences Questionnaire: development, validity and reliability.
- Published in:
- 2004
- By:
- Publication type:
- journal article
The Patient Experiences Questionnaire: development, validity and reliability.
- Published in:
- International Journal for Quality in Health Care, 2004, v. 16, n. 6, p. 453, doi. 10.1093/intqhc/mzh074
- By:
- Publication type:
- Article
FDG PET/CT and Dosimetric Studies of <sup>177</sup>Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
- Published in:
- Cytometry. Part B, 2017, v. 92, n. 1, p. 79, doi. 10.1002/cyto.b.21498
- By:
- Publication type:
- Article
Antibodies to granulocytes detected by an indirect immunofluorescence method not requiring chemical modification of cells.
- Published in:
- Transfusion, 1985, v. 25, n. 2, p. 165, doi. 10.1046/j.1537-2995.1985.25285169213.x
- By:
- Publication type:
- Article
A systematic safety pipeline for selection of T-cell receptors to enter clinical use.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00713-y
- By:
- Publication type:
- Article
Primary treatment with autologous stem cell transplantation in mantle cell lymphoma: outcome related to remission pretransplant.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 2, p. 73, doi. 10.1034/j.1600-0609.2003.00093.x
- By:
- Publication type:
- Article
Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin's lymphoma with the anti-CD37 radioimmunoconjugate <sup>212</sup>Pb-NNV003.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0230526
- By:
- Publication type:
- Article
Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma.
- Published in:
- Histopathology, 2015, v. 67, n. 1, p. 62, doi. 10.1111/his.12624
- By:
- Publication type:
- Article
IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S403, doi. 10.1016/S2152-2650(21)01911-X
- By:
- Publication type:
- Article
Poster: IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01539-1
- By:
- Publication type:
- Article
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate <sup>177</sup>Lu-Lilotomab Satetraxetan.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 4, p. 704, doi. 10.2967/jnumed.117.195347
- By:
- Publication type:
- Article
Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with <sup>177</sup>Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 55, doi. 10.2967/jnumed.116.180471
- By:
- Publication type:
- Article
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate <sup>177</sup>Lu-Lilotomab Satetraxetan.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 1, p. 48, doi. 10.2967/jnumed.116.173922
- By:
- Publication type:
- Article
T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 8, p. 1821, doi. 10.1002/ijc.26209
- By:
- Publication type:
- Article
Pre‐treatment health‐related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 1, p. 22, doi. 10.1002/hon.2940
- By:
- Publication type:
- Article
Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Molecular cytogenetic characterization of t(14;19)(q32;p13), a new recurrent translocation in B cell malignancies.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2007, v. 450, n. 5, p. 559, doi. 10.1007/s00428-007-0407-6
- By:
- Publication type:
- Article
Myelosuppression in patients treated with <sup>177</sup>Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable.
- Published in:
- Acta Oncologica, 2021, v. 60, n. 11, p. 1481, doi. 10.1080/0284186X.2021.1959635
- By:
- Publication type:
- Article
Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 5, p. 680, doi. 10.3109/0284186X.2013.855816
- By:
- Publication type:
- Article
Anti-CD37 radioimmunotherapy with <sup>177</sup>Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro.
- Published in:
- PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0267543
- By:
- Publication type:
- Article
Structure of conduct problems in adolescence.
- Published in:
- Scandinavian Journal of Psychology, 2002, v. 43, n. 1, p. 81, doi. 10.1111/1467-9450.00271
- By:
- Publication type:
- Article
Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis.
- Published in:
- Immunology, 2016, v. 149, n. 1, p. 62, doi. 10.1111/imm.12629
- By:
- Publication type:
- Article
Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 5, p. 0, doi. 10.1111/bjh.12073
- By:
- Publication type:
- Article
Error in a study of the outcome of mantle cell lymphoma: Nordic MCL2 Trial Update: 6-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 6, p. 815, doi. 10.1111/bjh.12006
- By:
- Publication type:
- Article
Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.
- Published in:
- British Journal of Haematology, 2012, v. 158, n. 3, p. 355, doi. 10.1111/j.1365-2141.2012.09174.x
- By:
- Publication type:
- Article
High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 600, doi. 10.1111/j.1365-2141.2010.08519.x
- By:
- Publication type:
- Article
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1902, doi. 10.1007/s00259-020-05098-x
- By:
- Publication type:
- Article
Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate <sup>177</sup>Lu-NNV003.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 11, p. 2311, doi. 10.1007/s00259-019-04417-1
- By:
- Publication type:
- Article
Pre-dosing with lilotomab prior to therapy with <sup>177</sup>Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 7, p. 1233, doi. 10.1007/s00259-018-3964-9
- By:
- Publication type:
- Article
Allogen stamcelletransplantasjon hos voksne 1985 - 2012.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2014, n. 16, p. 1569, doi. 10.4045/tidsskr.13.1415
- By:
- Publication type:
- Article
Høydosebehandling med autolog stamcellestøtte ved lymfom - fra utprøvende til standard behandling.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2013, n. 16, p. 1735, doi. 10.4045/tidsskr.13.0319
- By:
- Publication type:
- Article
Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987-2008.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2013, n. 16, p. 1704, doi. 10.4045/tidsskr.13.0243
- By:
- Publication type:
- Article
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 478, doi. 10.1186/1471-2407-12-478
- By:
- Publication type:
- Article